Read more
10:08 PM · 24 July 2025

Daily summary: Wall Street mixed on earnings; euro gains on hints of ECB pause (24.07.2025)

  • Wall Street sentiment remains mixed as investors react differently to key earnings reports. The S&P 500 and Nasdaq are currently up around 0.3%, while the Dow Jones and Russell 2000 are down 0.4% and 1.1%, respectively.

  • IBM (IBM.US) posted mostly better-than-expected results, but weakness in its core software segment disappointed investors and raised concerns about the company’s ability to raise its revenue outlook for H2 2025. The stock is down 7.7%.

  • Honeywell (HONE.US) beat Q2 2025 expectations, reporting EPS of $2.75. Revenue rose 8% to $10.35 billion, driven by growth in the Building Automation and Defense segments, which held up despite margin pressures.

  • UnitedHealth (UNH.US) is down nearly 4% after the U.S. Department of Justice launched an investigation into its Medicare billing practices. The company faces allegations of potential fraud related to inflated diagnoses.

  • Chevron (CVX.US) received White House approval to continue oil production in Venezuela. The decision is part of broader U.S.–Venezuela negotiations, which also included a prisoner exchange.

  • PMI indicators for the U.S. sent mixed signals about private sector conditions. Growth came primarily from the services sector, where both employment and orders rose. In contrast, the manufacturing sector unexpectedly contracted (49.5 vs. 52.7 expected, prior 52.9) due to tariffs and rising labor costs.

  • New jobless claims again came in below expectations (217K vs. 227K forecast, prior 221K), aligning with the Fed’s narrative of a stable U.S. labor market.

  • The European Central Bank kept interest rates unchanged, in line with expectations (deposit rate at 2%). Inflation is seen as on track to meet the medium-term target, and Q2 economic activity exceeded forecasts thanks to strong exports ahead of new tariffs. ECB President Christine Lagarde said the current rate level is appropriate, and the bank may wait before any policy changes. Markets currently price in no rate cuts for 2025.

  • On the forex market, the euro is strengthening following a de facto pause in the easing cycle (EURUSD: +0.03% to 1.177, EURJPY: +0.2%, EURGBP: +0.5%, EURCHF: +0.2%). The U.S. dollar is firming mainly against safe-haven currencies like the franc (USDCHF: +0.3%) and the yen (USDJPY: +0.25%).

  • Precious metals are pulling back amid rising risk appetite. Gold is down 0.5% to $3,371/oz, silver down 0.55% to $39.07/oz, and platinum down 1% to $1,413/oz.

  • NATGAS is rebounding 0.9% after today’s EIA report, while Brent and WTI crude are trading relatively flat at $67.9 and $65.6 per barrel, respectively.

  • Cryptocurrencies are in the green: Bitcoin is up 0.9% to $119,400, Ethereum up 3.8% to $3,733. Gains are also seen in Chainlink (+3%), Ripple (+3.1%), and Polygon (+1.6%).

 

14 April 2026, 4:52 PM

Wells Fargo Q1 2026: Profit Growth Masks Deterioration in Earnings Quality

14 April 2026, 4:30 PM

BREAKING: US PPI comes in weaker than expected. EURUSD gains ground

14 April 2026, 3:47 PM

JP Morgan earnings: Good, but it could have been better

14 April 2026, 3:13 PM

BlackRock earnings: Dynamic growth in the first quarter

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.